Pharmaceutical Representative Training

JANUARY 8, 2025

Pharmacology is one of the most fundamental aspects of medication therapy. 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Due to limited knowledge of pharmacology, the sales rep failed to properly communicate and was unable to address the physicians concerns.

Pharmacology 52

Pharmacology Pharma sales reps Sales Pharma 52

Pharmaceutical Technology

FEBRUARY 17, 2023

In 2021, the FDA granted Amgen’s (NASDAQ:AMGN) non-small cell lung cancer (NSCLC) drug Lumakras (sotorasib) an expedited approval, making it the first FDA-approved KRAS inhibitor. The demand came amid concerns that the drug causes a slew of side effects such as nausea, diarrhea, and liver issues.

FDA 115

FDA Side effects Pharmacology Patients 115

Impetus Digital

AUGUST 2, 2024

Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

Pharmaceutical Representative Training

JANUARY 30, 2025

3 Managing Side Effects : Balancing drug exposure and effect to achieve desired outcomes. This is especially critical in oncology, where chemotherapeutic agents require precise dosing to improve survival while minimizing side effects. Rang & Dale’s Pharmacology. Accessed January 3, 2025.

Pharmacology 52

Pharmacology Side effects Distribution Sales 52

Pharmaceutical Technology

OCTOBER 10, 2022

In December 2021, Amsterdam-based Freya acquired Lybrido, a tablet consisting of testosterone and sildenafil, and Lybridos, a combination of testosterone and buspirone, from the Dutch biotech Emotional Brain. Moreover, some women may find certain side effects like sleepiness, seen with other alternatives, beneficial, adds Kingsberg and Simon.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

European Pharmaceutical Review

SEPTEMBER 22, 2023

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience. Lowe SL, Duggan Evans C, et al.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97